These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29779297)

  • 1. Cardiac rhythm management devices.
    Stevenson I; Voskoboinik A
    Aust J Gen Pract; 2018 May; 47(5):264-271. PubMed ID: 29779297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Leadless pacemakers and subcutaneously implantable cardioverter defibrillators].
    Stellbrink C; Hansky B; Meyer Zu Vilsendorf D
    Internist (Berl); 2018 Oct; 59(10):999-1010. PubMed ID: 30105398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New frontiers in cardiac devices.
    Dennis AS; Behar JM
    Br J Hosp Med (Lond); 2020 Oct; 81(10):92-103. PubMed ID: 33135932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
    Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
    Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leadless Pacemakers: State of the Art and Future Perspectives.
    Della Rocca DG; Gianni C; Di Biase L; Natale A; Al-Ahmad A
    Card Electrophysiol Clin; 2018 Mar; 10(1):17-29. PubMed ID: 29428139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices.
    Steffen MM; Osborn JS; Cutler MJ
    Med Clin North Am; 2019 Sep; 103(5):931-943. PubMed ID: 31378335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator.
    Tjong FVY; Brouwer TF; Koop B; Soltis B; Shuros A; Schmidt B; Swackhamer B; Quast AEB; Wilde AAM; Burke MC; Knops RE
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1487-1498. PubMed ID: 29759829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Future of implantable electrical cardiac devices].
    Daubert JC; Behaghel A; Leclercq C; Mabo P
    Bull Acad Natl Med; 2014 Mar; 198(3):473-87; discussion 487-8. PubMed ID: 26427291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
    Kusztal M; Nowak K
    J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leadless pacing: present and future of cardiac stimulation].
    Piro A; Lavalle C; Della Rocca DG; Scarparo P; Mancone M; Maestrini V; Di Biase L; Natale A; Fedele F
    G Ital Cardiol (Rome); 2019 Jan; 20(1):32-40. PubMed ID: 30638213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD.
    Tjong FVY; Koop BE
    Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):355-361. PubMed ID: 30382341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leadless pacing.
    Sperzel J; Hamm C; Hain A
    Herz; 2018 Nov; 43(7):605-611. PubMed ID: 30255304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leadless pacemaker: Performance and complications.
    Lee JZ; Mulpuru SK; Shen WK
    Trends Cardiovasc Med; 2018 Feb; 28(2):130-141. PubMed ID: 28826669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defibrillators: Selecting the Right Device for the Right Patient.
    Al-Khatib SM; Friedman P; Ellenbogen KA
    Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac remodelling and function after cardiovascular implantable electronic devices implantation].
    Stanek A; Lelakowski J; Matusik PT
    Pol Merkur Lekarski; 2019 Apr; 46(274):187-189. PubMed ID: 31099767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on cardiac implantable electronic devices: from the injectable loop recorder to the leadless pacemaker, to the subcutaneous defibrillator.
    Santini M; Santini L; Di Fusco SA
    Minerva Cardioangiol; 2018 Dec; 66(6):762-769. PubMed ID: 30468062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.